Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Invited Review

Rodent Models and Imaging Techniques to Study Liver Regeneration

Wei W.a · Dirsch O.b · Lawson Mclean A.c · Zafarnia S.d · Schwier M.e · Dahmen U.a

Author affiliations

aDepartment of General, Visceral and Vascular Surgery, and bInstitute of Pathology, Jena University Hospital, and cFaculty of Medicine, Friedrich Schiller University, Jena, dDepartment of Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Aachen, and eFraunhofer Institute for Medical Image Computing MEVIS, Bremen, Germany

Related Articles for ""

Eur Surg Res 2015;54:97-113

Do you have an account?

Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Invited Review

Received: July 03, 2014
Accepted: September 19, 2014
Published online: November 12, 2014
Issue release date: February 2015

Number of Print Pages: 17
Number of Figures: 3
Number of Tables: 1

ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)

For additional information: https://www.karger.com/ESR

Abstract

The liver has the unique capability of regeneration from various injuries. Different animal models and in vitro methods are used for studying the processes and mechanisms of liver regeneration. Animal models were established either by administration of hepatotoxic chemicals or by surgical approach. The administration of hepatotoxic chemicals results in the death of liver cells and in subsequent hepatic regeneration and tissue repair. Surgery includes partial hepatectomy and portal vein occlusion or diversion: hepatectomy leads to compensatory regeneration of the remnant liver lobe, whereas portal vein occlusion leads to atrophy of the ipsilateral lobe and to compensatory regeneration of the contralateral lobe. Adaptation of modern radiological imaging technologies to the small size of rodents made the visualization of rodent intrahepatic vascular anatomy possible. Advanced knowledge of the detailed intrahepatic 3D anatomy enabled the establishment of refined surgical techniques. The same technology allows the visualization of hepatic vascular regeneration. The development of modern histological image analysis tools improved the quantitative assessment of hepatic regeneration. Novel image analysis tools enable us to quantify reliably and reproducibly the proliferative rate of hepatocytes using whole-slide scans, thus reducing the sampling error. In this review, the refined rodent models and the newly developed imaging technology to study liver regeneration are summarized. This summary helps to integrate the current knowledge of liver regeneration and promises an enormous increase in hepatological knowledge in the near future. © 2014 S. Karger AG, Basel

© 2014 S. Karger AG, Basel


References

  1. Donati M, Stavrou GA, Oldhafer KJ: Current position of ALPPS in the surgical landscape of CRLM treatment proposals. World J Gastroenterol 2013;19:6548-6554.
  2. Gaglio PJ, Liu H, Dash S, Cheng S, Dunne B, Ratterree M, Baskin G, Blanchard J, Bohm R Jr, Theise ND, LaBrecque D: Liver regeneration investigated in a non-human primate model (Macaca mulatta). J Hepatol 2002;37:625-632.
  3. Krupski G, Broring DC, Wittkugel O, Muller L, Nicolas V, Rogiers X, Adam G, Bucheler E: Formation of portal venous collaterals after ligation of the portal vein for induction of liver regeneration. Rofo 2002;174:1281-1284.
  4. Mortensen KE, Revhaug A: Liver regeneration in surgical animal models - a historical perspective and clinical implications. Eur Surg Res 2011;46:1-18.
  5. Huisman F, van Lienden KP, Damude S, Hoekstra LT, van Gulik TM: A review of animal models for portal vein embolization. J Surg Res 2014;191:179-188.
  6. Khan RA, Khan MR, Sahreen S: CCl4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat. BMC Complement Altern Med 2012;12:178.
  7. Palmes D, Spiegel HU: Animal models of liver regeneration. Biomaterials 2004;25:1601-1611.
  8. Bruccoleri A, Gallucci R, Germolec DR, Blackshear P, Simeonova P, Thurman RG, Luster MI: Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 1997;25:133-141.
  9. Liu KX, Kato Y, Yamazaki M, Higuchi O, Nakamura T, Sugiyama Y: Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride-intoxicated rats. Hepatology 1993;17:651-660.
  10. Rozga J, Foss A, Alumets J, Ahren B, Jeppsson B, Bengmark S: Liver cirrhosis in rats: regeneration and assessment of the role of phenobarbital. J Surg Res 1991;51:329-335.
  11. Michalopoulos GK: Liver regeneration. J Cell Physiol 2007;213:286-300.
  12. Rahman TM, Hodgson HJ: Animal models of acute hepatic failure. Int J Exp Pathol 2000;81:145-157.
  13. Keppler D, Lesch R, Reutter W, Decker K: Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 1968;9:279-290.
  14. Baumgartner D, LaPlante-O'Neill PM, Sutherland DE, Najarian JS: Effects of intrasplenic injection of hepatocytes, hepatocyte fragments and hepatocyte culture supernatants on D-galactosamine-induced liver failure in rats. Eur Surg Res 1983;15:129-135.
  15. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, Farber JM: Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 2001;167:399-406.
  16. Mao SA, Glorioso JM, Nyberg SL: Liver regeneration. Transl Res 2014;163:352-362.
  17. Matsuda H, Ninomiya K, Morikawa T, Yoshikawa M: Inhibitory effect and action mechanism of sesquiterpenes from Zedoariae Rhizoma on D-galactosamine/lipopolysaccharide-induced liver injury. Bioorg Med Chem Lett 1998;8:339-344.
  18. Zieve L, Anderson WR, Dozeman R, Draves K, Lyftogt C: Acetaminophen liver injury: sequential changes in two biochemical indices of regeneration and their relationship to histologic alterations. J Lab Clin Med 1985;105:619-624.
    External Resources
  19. Leonard TB, Morgan DG, Dent JG: Ranitidine-acetaminophen interaction: effects on acetaminophen-induced hepatotoxicity in Fischer 344 rats. Hepatology 1985;5:480-487.
  20. Fisher JE, McKenzie TJ, Lillegard JB, Yu Y, Juskewitch JE, Nedredal GI, Brunn GJ, Yi ES, Malhi H, Smyrk TC, Nyberg SL: Role of Kupffer cells and Toll-like receptor 4 in acetaminophen-induced acute liver failure. J Surg Res 2013;180:147-155.
  21. Shah N, Montes de Oca M, Jover-Cobos M, Tanamoto K, Muroi M, Sugiyama K, Davies NA, Mookerjee RP, Dhar DK, Jalan R: Role of Toll-like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure. Liver Transpl 2013;19:751-761.
  22. Gardner CR, Laskin JD, Dambach DM, Sacco M, Durham SK, Bruno MK, Cohen SD, Gordon MK, Gerecke DR, Zhou P, Laskin DL: Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-alpha and interleukin-10. Toxicol Appl Pharmacol 2002;184:27-36.
  23. Koen YM, Sarma D, Hajovsky H, Galeva NA, Williams TD, Staudinger JL, Hanzlik RP: Protein targets of thioacetamide metabolites in rat hepatocytes. Chem Res Toxicol 2013;26:564-574.
  24. Pallottini V, Martini C, Bassi AM, Romano P, Nanni G, Trentalance A: Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content. J Hepatol 2006;44:368-374.
  25. Honda H, Ikejima K, Hirose M, Yoshikawa M, Lang T, Enomoto N, Kitamura T, Takei Y, Sato N: Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology 2002;36:12-21.
  26. Bautista M, Del Rio MA, Benedi J, Sanchez-Reus MI, Morales-Gonzalez JA, Tellez-Lopez AM, Lopez-Orozco M: Effect of dichloromethylene diphosphonate on liver regeneration following thioacetamide-induced necrosis in rats. World J Hepatol 2013;5:379-386.
  27. Traber PG, Chou H, Zomer E, Hong F, Klyosov A, Fiel MI, Friedman SL: Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease. PLoS One 2013;8:e75361.
  28. Yang YL, Li JJ, Ji R, Wei YY, Chen J, Dou KF, Wang YY: Abnormal chloride homeostasis in the substancia nigra pars reticulata contributes to locomotor deficiency in a model of acute liver injury. PLoS One 2013;8:e65194.
  29. Kim JH, Jeong YJ, Hong JM, Kim HR, Kang JS, Lee WJ, Hwang YI: Chronic vitamin C insufficiency aggravated thioacetamide-induced liver fibrosis in gulo-knockout mice. Free Radic Biol Med 2014;67:81-90.
  30. Mathews S, Xu M, Wang H, Bertola A, Gao B: Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest Liver Physiol 2014;306:G819-G823.
  31. Gao B, Bataller R: Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011;141:1572-1585.
  32. Vidhya A, Renjugopal V, Indira M: Impact of thiamine supplementation in the reversal of ethanol induced toxicity in rats. Indian J Physiol Pharmacol 2013;57:406-417.
    External Resources
  33. Enomoto N, Ikejima K, Yamashina S, Hirose M, Shimizu H, Kitamura T, Takei Y, Sato AN, Thurman RG: Kupffer cell sensitization by alcohol involves increased permeability to gut-derived endotoxin. Alcohol Clin Exp Res 2001;25:51S-54S.
  34. Rao R: Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 2009;50:638-644.
  35. Ding X, Beier JI, Baldauf KJ, Jokinen JD, Zhong H, Arteel GE: Acute ethanol preexposure promotes liver regeneration after partial hepatectomy in mice by activating ALDH2. Am J Physiol Gastrointest Liver Physiol 2014;306:G37-G47.
  36. He S, Rehman H, Shi Y, Krishnasamy Y, Lemasters JJ, Schnellmann RG, Zhong Z: Suramin decreases injury and improves regeneration of ethanol-induced steatotic partial liver grafts. J Pharmacol Exp Ther 2013;344:417-425.
  37. Koteish A, Yang S, Lin H, Huang J, Diehl AM: Ethanol induces redox-sensitive cell-cycle inhibitors and inhibits liver regeneration after partial hepatectomy. Alcohol Clin Exp Res 2002;26:1710-1718.
  38. Zhang BH, Hornsfield BP, Farrell GC: Chronic ethanol administration to rats decreases receptor-operated mobilization of intracellular ionic calcium in cultured hepatocytes and inhibits 1,4,5-inositol trisphosphate production: relevance to impaired liver regeneration. J Clin Invest 1996;98:1237-1244.
  39. Diehl AM, Thorgeirsson SS, Steer CJ: Ethanol inhibits liver regeneration in rats without reducing transcripts of key protooncogenes. Gastroenterology 1990;99:1105-1112.
    External Resources
  40. Martins PN, Theruvath TP, Neuhaus P: Rodent models of partial hepatectomies. Liver Int 2008;28:3-11.
  41. Madrahimov N, Dirsch O, Broelsch C, Dahmen U: Marginal hepatectomy in the rat: from anatomy to surgery. Ann Surg 2006;244:89-98.
  42. Martins PN, Neuhaus P: Surgical anatomy of the liver, hepatic vasculature and bile ducts in the rat. Liver Int 2007;27:384-392.
  43. Weinbren K, Woodward E: Delayed incorporation of 32P from orthophosphate into deoxyribonucleic acid of rat liver after subtotal hepatectomy. Br J Exp Pathol 1964;45:442-449.
    External Resources
  44. Gaub J, Iversen J: Rat liver regeneration after 90% partial hepatectomy. Hepatology 1984;4:902-904.
  45. Deng M, Huang H, Jin H, Dirsch O, Dahmen U: The anti-proliferative side effects of AEE788, a tyrosine kinase inhibitor blocking both EGF- and VEGF-receptor, are liver-size-dependent after partial hepatectomy in rats. Invest New Drugs 2011;29:593-606.
  46. Mitchell C, Willenbring H: A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc 2008;3:1167-1170.
  47. Kubota T, Takabe K, Yang M, Sekido H, Endo I, Ichikawa Y, Togo S, Shimada H: Minimum sizes for remnant and transplanted livers in rats. J Hepatobiliary Pancreat Surg 1997;4:398-404.
    External Resources
  48. Fausto N: Liver regeneration. J Hepatol 2000;32:19-31.
  49. Ota S, Suzuki S, Sakaguchi T, Baba S, Mitsuoka H, Nakamura S, Konno H: Significance of morphological alteration by portal vein branch ligation in endotoxin-induced liver injury after partial hepatectomy. Liver Int 2007;27:1076-1085.
  50. Abshagen K, Mertens F, Eipel C, Vollmar B: Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers. Int J Clin Exp Pathol 2013;6:1759-1769.
    External Resources
  51. Marsman HA, de Graaf W, Heger M, van Golen RF, Ten Kate FJ, Bennink R, van Gulik TM: Hepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acids. Br J Surg 2013;100:674-683.
  52. Itoh T, Miyajima A: Liver regeneration by stem/progenitor cells. Hepatology 2014;59:1617-1626.
  53. Park ES, Park YK, Shin CY, Park SH, Ahn SH, Kim DH, Lim KH, Kwon SY, Kim KP, Yang SI, Seong BL, Kim KH: Hepatitis B virus inhibits liver regeneration via epigenetic regulation of urokinase-type plasminogen activator. Hepatology 2013;58:762-776.
  54. Quetier I, Brezillon N, Duriez M, Massinet H, Giang E, Ahodantin J, Lamant C, Brunelle MN, Soussan P, Kremsdorf D: Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice. J Hepatol 2013;59:285-291.
  55. Chavin KD, Yang S, Lin HZ, Chatham J, Chacko VP, Hoek JB, Walajtys-Rode E, Rashid A, Chen CH, Huang CC, Wu TC, Lane MD, Diehl AM: Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 1999;274:5692-5700.
  56. Torbenson M, Yang SQ, Liu HZ, Huang J, Gage W, Diehl AM: STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol 2002;161:155-161.
  57. Wilms C, Mueller L, Lenk C, Wittkugel O, Helmke K, Krupski-Berdien G, Rogiers X, Broering DC: Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 2008;247:825-834.
  58. van den Esschert JW, van Lienden KP, Alles LK, van Wijk AC, Heger M, Roelofs JJ, van Gulik TM: Liver regeneration after portal vein embolization using absorbable and permanent embolization materials in a rabbit model. Ann Surg 2012;255:311-318.
  59. Tashiro S: Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different? J Hepatobiliary Pancreat Surg 2009;16:292-299.
  60. Gock M, Eipel C, Linnebacher M, Klar E, Vollmar B: Impact of portal branch ligation on tissue regeneration, microcirculatory response and microarchitecture in portal blood-deprived and undeprived liver tissue. Microvasc Res 2011;81:274-280.
  61. Lambotte L, Li B, Leclercq I, Sempoux C, Saliez A, Horsmans Y: The compensatory hyperplasia (liver regeneration) following ligation of a portal branch is initiated before the atrophy of the deprived lobes. J Hepatol 2000;32:940-945.
  62. Rous P, Larimore LD: Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J Exp Med 1920;31:609-632.
  63. Rozga J, Jeppsson B, Bengmark S: Portal branch ligation in the rat. Reevaluation of a model. Am J Pathol 1986;125:300-308.
    External Resources
  64. Weinbren K, Tarsh E: The mitotic response in the rat liver after different regenerative stimuli. Br J Exp Pathol 1964;45:475-480.
    External Resources
  65. Tivers MS, Lipscomb VJ, Smith KC, Wheeler-Jones CP, House AK: Markers of hepatic regeneration associated with surgical attenuation of congenital portosystemic shunts in dogs. Vet J 2014;200:305-311.
  66. Ladurner R, Schenk M, Margreiter R, Offner F, Konigsrainer A: Influence of portosystemic shunt on liver regeneration after hepatic resection in pigs. HPB Surg 2009;2009:835965.
  67. Aller MA, Martinez V, Corcuera MT, Benito J, Traver E, Gomez-Aguado F, Vergara P, Arias J: Liver impairment after portacaval shunt in the rat: the loss of protective role of mast cells? Acta Histochem 2012;114:301-310.
  68. Garcia C, Gine E, Aller MA, Revuelta E, Arias JL, Vara E, Arias J: Multiple organ inflammatory response to portosystemic shunt in the rat. Cytokine 2011;56:680-687.
  69. Starzl TE, Porter KA, Francavilla A: The Eck fistula in animals and humans. Curr Probl Surg 1983;20:687-752.
  70. Klarik Z, Toth E, Kiss F, Miko I, Furka I, Nemeth N: A modified microsurgical model for end-to-side selective portacaval shunt in the rat. Intraoperative microcirculatory investigations. Acta Cir Bras 2013;28:625-631.
  71. Erlik D, Barzilai A, Shramek A: Porto-renal shunt: a new technic for porto-systemic anastomosis in portal hypertension. Ann Surg 1964;159:72-78.
  72. Warren WD, Zeppa R, Fomon JJ: Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967;166:437-455.
  73. Alwayn IP, Verbesey JE, Kim S, Roy R, Arsenault DA, Greene AK, Novak K, Laforme A, Lee S, Moses MA, Puder M: A critical role for matrix metalloproteinases in liver regeneration. J Surg Res 2008;145:192-198.
  74. Sugimoto T, Yamada T, Iwata H, Sekino T, Matsumoto S, Ishida N, Manabe H, Kimura M, Takemura H: Two-stage portal vein ligation facilitates liver regeneration in rats. Eur Surg Res 2009;42:181-188.
  75. Garbow JR, Kataoka M, Flye MW: MRI measurement of liver regeneration in mice following partial hepatectomy. Magn Reson Med 2004;52:177-180.
  76. Fulop A, Szijarto A, Harsanyi L, Budai A, Pekli D, Korsos D, Horvath I, Kovacs N, Karlinger K, Mathe D, Szigeti K: Demonstration of metabolic and cellular effects of portal vein ligation using multi-modal PET/MRI measurements in healthy rat liver. PLoS One 2014;9:e90760.
  77. Radtke A, Sotiropoulos GC, Molmenti EP, Sgourakis G, Schroeder T, Beckebaum S, Peitgen HO, Cicinnati VR, Broelsch CE, Broering DC, Malago M: Transhilar passage in right graft live donor liver transplantation: intrahilar anatomy and its impact on operative strategy. Am J Transplant 2012;12:718-727.
  78. Nebuloni L, Kuhn GA, Muller R: A comparative analysis of water-soluble and blood-pool contrast agents for in vivo vascular imaging with micro-CT. Acad Radiol 2013;20:1247-1255.
  79. Ringe KI, Husarik DB, Gupta RT, Boll DT, Merkle EM: Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system - what is normal? Eur J Radiol 2011;79:201-205.
  80. Wu J, Li H, Lin Y, Chen Z, Zhong Q, Gao H, Fu L, Sandrasegaran K: Value of gadoxetate biliary transit time in determining hepatocyte function. Abdom Imaging 2014, Epub ahead of print.
  81. Selle D, Preim B, Schenk A, Peitgen HO: Analysis of vasculature for liver surgical planning. IEEE Trans Med Imaging 2002;21:1344-1357.
  82. de Graaf W, Bennink RJ, Heger M, Maas A, de Bruin K, van Gulik TM: Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. J Nucl Med 2011;52:294-302.
  83. Lehner B, Sandner B, Marschallinger J, Lehner C, Furtner T, Couillard-Despres S, Rivera FJ, Brockhoff G, Bauer HC, Weidner N, Aigner L: The dark side of BrdU in neural stem cell biology: detrimental effects on cell cycle, differentiation and survival. Cell Tissue Res 2011;345:313-328.
  84. Bullwinkel J, Baron-Luhr B, Ludemann A, Wohlenberg C, Gerdes J, Scholzen T: Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol 2006;206:624-635.
  85. Deng M, Dirsch O, Sun J, Huang H, Sehestedt C, Homeyer A, Schenk A, Dahmen U: Limited correlation between conventional pathologist and automatic computer-assisted quantification of hepatic steatosis due to difference between event-based and surface-based analysis. IEEE J Biomed Health Inform 2013;18:1473-1477.
  86. Homeyer A, Schenk A, Dahmen U, Dirsch O, Huang H, Hahn HK: A comparison of sampling strategies for histological image analysis. J Pathol Inform 2011;2:S11.
  87. Homeyer A, Schenk A, Arlt J, Dahmen U, Dirsch O, Hahn HK: Practical quantification of necrosis in histological whole-slide images. Comput Med Imaging Graph 2013;37:313-322.
  88. Wang K, Lee I, Carlson G, Hood L, Galas D: Systems biology and the discovery of diagnostic biomarkers. Dis Markers 2010;28:199-207.
  89. Sauer U, Heinemann M, Zamboni N: Genetics. Getting closer to the whole picture. Science 2007;316:550-551.
  90. Schwen LO, Krauss M, Niederalt C, Gremse F, Kiessling F, Schenk A, Preusser T, Kuepfer L: Spatio-temporal simulation of first pass drug perfusion in the liver. PLoS Comput Biol 2014;10:e1003499.
  91. Hohme S, Hengstler JG, Brulport M, Schafer M, Bauer A, Gebhardt R, Drasdo D: Mathematical modelling of liver regeneration after intoxication with CCl(4). Chem Biol Interact 2007;168:74-93.
  92. Ricken T, Dahmen U, Dirsch O: A biphasic model for sinusoidal liver perfusion remodeling after outflow obstruction. Biomech Model Mechanobiol 2010;9:435-450.
  93. Hoehme S, Brulport M, Bauer A, Bedawy E, Schormann W, Hermes M, Puppe V, Gebhardt R, Zellmer S, Schwarz M, Bockamp E, Timmel T, Hengstler JG, Drasdo D: Prediction and validation of cell alignment along micro vessels as order principle to restore tissue architecture in liver regeneration. Proc Natl Acad Sci USA 2010;107:10371-10376.
  94. Hohmann N, Weiwei W, Dahmen U, Dirsch O, Deutsch A, Voss-Bohme A: How does a single cell know when the liver has reached its correct size? PLoS One 2014;9:e93207.
  95. Periwal V, Gaillard JR, Needleman L, Doria C: Mathematical model of liver regeneration in human live donors. J Cell Physiol 2014;229:599-606.

Article / Publication Details

First-Page Preview
Abstract of Invited Review

Received: July 03, 2014
Accepted: September 19, 2014
Published online: November 12, 2014
Issue release date: February 2015

Number of Print Pages: 17
Number of Figures: 3
Number of Tables: 1

ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)

For additional information: https://www.karger.com/ESR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.